Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Preventive healthcare use among males with multiple sclerosis.
Fine-tuning the central nervous system: microglial modelling of cells and synapses.
MULTIPLE SCLEROSIS: MOLECULAR MECHANISMS AND THERAPEUTIC OPPORTUNITIES.
Role of Platelets in Neurodegenerative Diseases: A Universal Pathophysiology.
Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
Agreement between physician's recommendation and fitness-to-drive decision in multiple sclerosis.
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis.
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice.
Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination.
Structure of the first sphingosine 1-phosphate receptor.
[Lyme disease in patients with multiple sclerosis: clinical, diagnostic and therapeutic features.]
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.
Studies of EN-1639A (naltrexone): a new narcotic antagonist.
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Heat shock protein 27 in multiple sclerosis relapses.
Structure and Activity of the Acid Sensing Ion Channels.
Added benefit of fampridine is not proven
Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model.
In situ expansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS.
B cells and antibodies in multiple sclerosis pathogenesis and therapy.
Association between multiple sclerosis and chronic periodontitis: a population-based pilot study.
Pages
« first
‹ previous
…
188
189
190
191
192
193
194
195
196
…
next ›
last »